from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2114/-

LFCtreatmentdescriptionclass of inhibitor

0.276

Amikacinug/mL Amikacintranslation

0.410

Cap5-10ug/mL Capreomycintranslation

0.184

Rox10-50 ug/mL Roxithromycintranslation

0.395

SM2-5 ug/mL Streptomycintranslation

0.644

Tet5-10 ug/mL Tetracyclinetranslation

0.449

Rif0.2-5ug/mL Rifampicintranscription

0.352

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.292

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.441

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.831

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.863

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.241

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.482

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.891

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.574

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.285

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.567

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.968

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-2.119

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.152

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.825

KCN5-20 ug/mL Potassium cyaniderespiration

-0.694

NaN30.2-2 mM Sodium aziderespiration

0.985

Nigericin50 uM Nigericinrespiration

-0.595

TRC10-150 ug/mL Triclosanrespiration

-2.179

TRZ10-25 ug/mL Thioridazinerespiration

-0.747

Valinomycin0.5-10 uM Valinomycinrespiration

1.056

ZnSO42 mM ZnSO4respiration

-0.216

menadione6-10 ug/mL Menadionerespiration

-0.203

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.586

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.104

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.869

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.912

NRP_1Non-replicating persistence stage 1dosRassociated

0.427

Amp0.2mg/mL AmpicillincellWall

-0.001

Cephalexin20-100 ug/mL CephalexincellWall

0.797

Cerulenin0.32-5 ug/mL CerulenincellWall

0.223

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.556

EMB10-20 ug/mL EthambutolcellWall

0.726

Eta12-40 ug/mL EthionamidecellWall

0.620

INH0.2-0.4 ug/mL IsoniazidcellWall

0.596

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.426

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.531

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.438

BZA0.12 mg/mL BenzamidearomaticAmides

0.464

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.532

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.451

H2O24 mM hydrogen peroxideDNAdamaging

0.511

Levo10 ug/mL LevofloxacinDNAdamaging

0.602

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.452

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.365

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.386

UVUV-irradiationDNAdamaging

-0.738

ARP41-4 ug/mL Antitubercular compound ARP4?

0.758

Antimycin12.5-50 ug/mL Antimycin A?

0.568

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.148

PA_110-50 ug/mL Antitubercular compound PA-1?

0.089

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.857

PA8240.2-2 ug/mL PA-824?

-1.378

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.345

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.327

Verapamil50 uM Verapamil?

0.414

mercaptoethanol2 mM 2-Mercaptoethanol?

1.022

methoxatin10-20 ug/mL Methoxatin?